MedTrace Logo

Pediatric Cohort Study

NCT04561427 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-09-23

No results posted yet for this study

Summary

Narcolepsy is a rare disease that affects 0.05% of the general population. It is characterized by a dysregulation of the sleep wake regulation that leads to uncontrolled sleep episode during day and a disorganized sleep during night. These symptoms are due to a loss of hypocretin neurons in the brain leading to an inability to maintain wake properly. The physiopathology of this rare disease still needs investigations. Since we are a reference center for this disease, we propose to use patients files to better describe and document the sleep characteristics of these children, the cognitive performances, the effects of narcolepsy treatments on sleep architecture and the metabolic status of these children.

Conditions

  • Narcolepsy in Children

Interventions

OTHER

Study of Sleep architecture in children with narcolepsy

Evaluate the cognitive performances, the effects of narcolepsy treatments on sleep architecture and the metabolic status of these children

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2022-02-01
Completion
2022-02-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04561427 on ClinicalTrials.gov